Literature DB >> 3570967

In vitro antibacterial properties of EL-870, a new semi-synthetic macrolide antibiotic.

E E Ose.   

Abstract

A new macrolide antibiotic, EL-870, 20-deoxo-20-(3,5-dimethylpiperidin-1-yl)desmycosin, has been prepared by chemical modification of desmycosin. In vitro, against selected animal bacterial pathogens, it inhibited growth of Pasteurella multocida, Pasteurella haemolytica, Mycoplasma hyopneumoniae, Actinobacillus pleuropneumoniae, Streptococcus suis, Actinomyces pyogenes and certain other bacteria at levels of 6.25 micrograms/ml or less. In general, the MICs for Gram-negative enteric bacteria have been greater than 50 micrograms/ml. Concentrations equivalent to 4 X the MIC value were bactericidal for Pasteurella sp. EL-870 had other antibacterial properties which were characteristic of macrolide antibiotics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3570967     DOI: 10.7164/antibiotics.40.190

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  7 in total

1.  Tilmicosin as a single injection treatment for respiratory disease of feedlot cattle.

Authors:  P E Gorham; L H Carroll; J W McAskill; L E Watkins; E E Ose; L V Tonkinson; J K Merrill
Journal:  Can Vet J       Date:  1990-12       Impact factor: 1.008

2.  A study of tilmicosin residues in milk following subcutaneous administration to lactating dairy cows.

Authors:  S L Helton-Groce; T D Thomson; R S Readnour
Journal:  Can Vet J       Date:  1993-10       Impact factor: 1.008

3.  Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics.

Authors:  L Stipkovits; D Miller; R Glavits; L Fodor; D Burch
Journal:  Can J Vet Res       Date:  2001-10       Impact factor: 1.310

4.  Proposed quality control guidelines for antimicrobial susceptibility tests using tilmicosin.

Authors:  T R Shryock; D W White; C S Werner; J M Staples
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark.

Authors:  S A Salmon; J L Watts; C A Case; L J Hoffman; H C Wegener; R J Yancey
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  In vitro susceptibilities of Leptospira spp. and Borrelia burgdorferi isolates to amoxicillin, tilmicosin, and enrofloxacin.

Authors:  Doo Kim; Dorsey Kordick; Thomas Divers; Yung Fu Chang
Journal:  J Vet Sci       Date:  2006-12       Impact factor: 1.672

7.  Preparation and evaluation of tilmicosin-loaded hydrogenated castor oil nanoparticle suspensions of different particle sizes.

Authors:  Xiaojin Chen; Ting Wang; Mengmeng Lu; Luyan Zhu; Yan Wang; WenZhong Zhou
Journal:  Int J Nanomedicine       Date:  2014-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.